Rockwell Automation announces its OEM Partner Program Next Evolution

businesswire | November 24, 2020

Rockwell Automation, Inc. (NYSE: ROK), the world's biggest organization devoted to mechanical computerization and advanced change, today reported the following development of its worldwide Original Equipment Manufacturer (OEM) Partner Program. The improved contribution currently gives expanded market access openings, rearrangements, and normalized item arrangement for makers, empowering members to completely use Rockwell Automation innovation.

Rockwell Automation works with OEMs (additionally alluded to as Machine and Equipment Builders) over the globe to configuration, create, and convey imaginative hardware with Rockwell Automation arrangements. Those OEMs that show a promise to utilize Rockwell Automation contributions over their portfolio, and afterward viably accomplice to make inventive answers for their clients are perceived as OEM Partners. The OEM Partner Program is intended to more readily adjust clients to accomplices and encourage expanded development through Rockwell Automation's innovation and area ability.

First settled in 2010, the OEM Partner Program currently incorporates very nearly 3,300 producers around the world. The most recent development of the program expands on the effective specialized driven connection between Rockwell Automation and its part organizations, and now fuses significantly more prominent arrangement to all the more likely position OEMs as conveyance accomplices of Rockwell Automation items.
“The right OEM is critical to the success of a manufacturing operation,” said Dan Throne, OEM manager for North America at Rockwell Automation. “Customers need innovative machines that easily integrate into their operations. They require flexible and efficient equipment that increases business agility, optimizes productivity, and can turn mined data into working information capital. OEM Partners embrace this thinking and use Rockwell Automation technology and expertise to bring it to life.”

Aagard, an American-based engineering company that builds custom packaging automation systems, has been an OEM Partner for eight years.

“Rockwell Automation’s OEM Program has opened up many strategic opportunities, both from a technology perspective as well as identifying new unfilled niches with end-users.” said Jason Norlien, vice president of technical sales at Aagard. “Rockwell Automation has proven to be a true partner and our brand association has positioned ourselves as a premier player in the packaging sector offering real value to customers.”

Seat noticed that the OEM Partner Program has kept on advancing dependent on both the developing necessities of clients and program member criticism. Upgrades to the program include:

Co-Marketing and Information Sharing. A hearty co-showcasing stage for OEM clients to use data, industry contextual analyses, and triumphs with items to profit the network on the loose. Preparing and key industry plays have been added to expand the estimation of the co-showcasing between OEM Partners and their clients, further formalizing business arrangement.

Raised Level of Support. Expanded specialized assets and flexibly chain arrangement, notwithstanding limits and refunds that empower OEM Partners to make separation and conquer business challenges.

The upgraded OEM Partner Program is currently open for enlistment in North America, Asia, Europe, the Middle East, and Africa. Enlistment for the Latin America district will be accessible in the principal quarter of 2021.

About Rockwell Automation

Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 23,000 problem solvers dedicated to our customers in more than 100 countries.


ROI comes in many forms; a technological innovation that elevates throughput efficiency, a safety measure that promotes a less dangerous working environment, or a smart tool that ensures the accurate delivery of a product. This eBook demonstrates the many diverse uses for pressure mapping technology to help cultivate trust in your advanced manufacturing concept.

Other News

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

WuXi Biologics | June 06, 2022

WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi Biologics. The DP5 facility features an advanced isolator filling line for continuous and steady filling services, which offers multiple volume delivery options for pre-filled syringes (PFS), including 1 mL Long, 1 mL, 2.25 mL and 3 mL. The maximum filling speed can reach 400 PFS/min to support 17 million syringes of drug products manufacturing every year. The increased manufacturing capacity at DP5 allows WuXi Biologics to provide global partners with faster and more robust end-to-end drug product services for their innovative products at different scales and stages. Compared to a traditional drug product filling line, DP5's state-of-the-art design and layout, single-use technology and automated equipment, significantly decrease the risk of contamination and maintain aseptic control required in the filling process. This process supports clients' products scale up to commercial capability and reliably delivers to patients under the highest quality standards which WuXi Biologics represents. Dr. Chris Chen, CEO of WuXi Biologics, commented, "Pre-filled syringes have emerged as one of the fastest-growing choices for biologics dosage form as our partners seek new and more convenient biologics delivery methods. The GMP operation of DP5, our first commercial drug product facility for pre-filled syringes, not only demonstrates our commitment to global partners, but also marks an important milestone for WuXi Biologics to become one of the global leaders in drug product CDMO services. We'll continue to enable our clients to advance innovative biologics towards clinical trials, regulatory approvals, and commercialization to benefit patients worldwide." About WuXi Biologics WuXi Biologics (2269.HK) is a global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop, and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide. With over 10,000 skilled employees in China, the United States, Ireland, Germany, and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and cost-effective biologics discovery, development, and manufacturing solutions. As of the end of 2021, WuXi Biologics is supporting over 480 integrated client projects, including nine in commercial manufacturing. WuXi Biologics views Environmental, Social, and Governance (ESG) responsibilities as an integral component of our ethos and business strategy, and we aim to become an ESG leader in the biologics CRDMO sector. Our facilities use next-generation biomanufacturing technologies and clean energy sources. We have also established an ESG committee led by our CEO to steer the comprehensive ESG strategy and its implementation, further enhancing our commitment to sustainability.

Read More


Crown Laboratories Announces Expansion of Manufacturing Facility

Crown Laboratories, Inc. | July 13, 2022

Crown Laboratories ("Crown"), a leading, fully integrated global skincare company, announced today that it is adding 60,000 square feet to its manufacturing complex in Johnson City, TN. The facility is home to leading dermatological brands such as PanOxyl® acne wash, Blue Lizard® Australian Sunscreen, and Sarna® anti-itch lotion. The additional 60,000 sq. ft. will bring the Lafe Cox Drive facility to approximately 250,000 square feet – enough to accommodate the warehouse space that is required to keep up with Crown's growing manufacturing and packaging needs. The facility manufactures and distributes products for the global market, including prescription, medical devices, OTC and cosmetic products. It has been producing record numbers of finished goods on a consistent month over month basis. "We have been at maximum capacity for some time now, Our organization has grown significantly and as a result, our production demands have nearly doubled in the past couple of years. With that increased production comes additional componentry, cartons and materials. By expanding our warehouse and adding close to 5,000 pallet locations, we will be able to conduct our operations with more efficiency and with better financial controls." -Jeff Bedard, President and CEO of Crown. About Crown Laboratories, Inc. Crown, a privately held, fully integrated global skincare company, is committed to developing and providing a diverse portfolio of aesthetic, premium and therapeutic skincare products that improve the quality of life for its consumers throughout their skincare journey. An innovative company focused on skin science for life, Crown's unyielding pursuit of delivering therapeutic excellence and enhanced patient outcomes is why it has become the leader in dermatology and aesthetics. Crown has been listed on the Inc. 5000 Fastest Growing Privately Held Companies List for eight years and has expanded its distribution to over 38 countries.

Read More


Emerson Provides Advanced Automation Technology for Toyota Australia’s Hydrogen Production and Refueling Plant

Emerson | May 26, 2022

Global software and technology leader Emerson and Toyota Australia have collaborated to transform part of Toyota Australia’s operations into a commercial-grade hydrogen production, storage and refueling plant. The project, supported by the Australian Renewable Energy Agency (ARENA), adopts Emerson’s automation expertise to provide the control system that helps Toyota Australia demonstrate the technical and economic feasibility of manufacturing hydrogen fuels, including the use of renewable solar energy. As low and zero-emission vehicles capture an ever-greater share of the market, countries around the globe need to expand access to renewable fuels like hydrogen. Sustainable hydrogen projects are challenging because they need to integrate many data sources into one balance-of-plant system, a process that’s critical for a facility’s success. For the Toyota Australia Hydrogen Center, Emerson’s advanced DeltaV™ distributed control system gathers data from the plant’s complex equipment, making it easier to monitor production and storage of hydrogen gas and document and validate the sustainability of operations. “By incorporating a digital automation foundation to eliminate data silos, Toyota Australia can not only significantly reduce costs, but also gain greater visibility into system performance, making it easier to maintain and report sustainability performance and increase productivity, The data foundation Toyota has built will make it faster and easier for like-minded companies to replicate success as hydrogen refueling networks continue to expand across the continent and the globe.” Mark Bulanda, executive president of Emerson’s Automation Solutions business Emerson’s DeltaV systems control operations for optimal production efficiencies and help ensure safe operations. Edge control technology from Emerson’s PACSystems™ will further reduce cost and complexity of integrating third-party systems. Rosemount™ flame detectors will help keep personnel and operations safe. The Toyota Australia team took advantage of pre-existing configuration libraries to reduce setup time. In addition, Emerson’s technologies create a platform to add future remote operations and data analytics more easily and cost effectively. About Emerson Emerson headquartered in St. Louis, Missouri (USA), is a global technology and engineering company providing innovative solutions for customers in industrial, commercial and residential markets. Our Automation Solutions business helps process, hybrid and discrete manufacturers maximize production, protect personnel and the environment while optimizing their energy and operating costs. Our Commercial & Residential Solutions business helps ensure human comfort and health, protect food quality and safety, advance energy efficiency and create sustainable infrastructure. For more information visit About Toyota Toyota Motor Corporation works to develop and manufacture innovative, safe and high-quality products and services that create happiness by providing mobility for all. We believe that true achievement comes from supporting our customers, partners, employees, and the communities in which we operate. Since our founding over 80 years ago in 1937, we have applied our Guiding Principles in pursuit of a safer, greener and more inclusive society. Today, as we transform into a mobility company developing connected, automated, shared and electrified technologies, we also remain true to our Guiding Principles and many of the United Nations' Sustainable Development Goals to help realize an ever-better world, where everyone is free to move. In Australia, Toyota has been the best-selling automotive brand for 25 years, including the past 19 in a row.

Read More



Axcelis | July 14, 2022

Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced a significant increase in production levels and staffing at the Company's new Axcelis Asia Operations Center, located in Pyeongtaek-Si, Gyeonggi-Do, Korea. The new Axcelis Asia Operations Center is a state-of-the-art manufacturing and engineering facility that measures over 44,000 square feet and includes a fully functional cleanroom designed with the lean and quality principles that govern the Company's US manufacturing site. In addition, the new center is certified by the ISO 45001 Occupational Health and Safety Management System. The Axcelis Asia Operations Center is designed to serve both the Korean customer base, and our expanding footprint across all of Asia. The Company completed initial shipments from the new center in the first quarter. "Korea has long been a key region for Axcelis and this investment in the Axcelis Asia Operations Center in Korea will add manufacturing capacity to our operations, reduce lead-times, bring us closer to our customers and facilitate relationships with the local community. We also are excited to provide significant employment opportunities across a range of functions from manufacturing engineering, supply chain management, engineering and software development. We look forward to continuing to play a vibrant role in both the local community and supply chain." -Mary Puma President and CEO, Axcelis About Axcelis: Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process.

Read More


ROI comes in many forms; a technological innovation that elevates throughput efficiency, a safety measure that promotes a less dangerous working environment, or a smart tool that ensures the accurate delivery of a product. This eBook demonstrates the many diverse uses for pressure mapping technology to help cultivate trust in your advanced manufacturing concept.